Reckitt Benckiser Group (OTCMKTS:RBGLY) Sets New 52-Week High – Should You Buy?
by Michael Walen · The Markets DailyReckitt Benckiser Group PLC (OTCMKTS:RBGLY – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $16.25 and last traded at $16.25, with a volume of 34220 shares. The stock had previously closed at $15.94.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on RBGLY shares. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Reckitt Benckiser Group in a research report on Monday, October 27th. Barclays raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Monday, December 1st. Finally, Royal Bank Of Canada reiterated an “outperform” rating on shares of Reckitt Benckiser Group in a research report on Thursday, October 23rd. Two analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy”.
View Our Latest Research Report on RBGLY
Reckitt Benckiser Group Stock Performance
The firm’s 50 day moving average price is $15.54 and its 200-day moving average price is $14.88. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.56 and a quick ratio of 0.37.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Further Reading
- Five stocks we like better than Reckitt Benckiser Group
- Asset Allocation Strategies in Volatile Markets
- Top 3 Winter Stocks With Solid Growth Opportunities
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 2026 Comeback Picks: 3 S&P Laggards Poised to Break Out
- How to Invest in Small Cap Stocks
- Tesla Bulls See $500 Ahead—But Bears Warn of a Painful Reversal